ω-Substituted alkyl carboxylic acids as antidiabetic and lipid-lowering agents
- 31 October 1998
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 33 (10) , 775-787
- https://doi.org/10.1016/s0223-5234(99)80029-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Early molecular defects in human insulin resistance: studies in healthy subjects with low insulin sensitivityDiabetes/Metabolism Research and Reviews, 1997
- Thiazolidinediones in the treatment of insulin resistance and type II diabetesDiabetes, 1996
- Current concepts of renal hemodynamics in diabetesJournal of Diabetes and its Complications, 1995
- Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overviewDiabetologia, 1992
- Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in
C 57BL KsJ db db Metabolism, 1991 - Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular DiseaseDiabetes Care, 1991
- Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob miceDiabetes, 1990
- Cellular Mechanism of Action of MetforminDiabetes Care, 1990
- Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes, 1988
- Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic ratsDiabetes, 1983